Beli & Jual Millennium Pharmacon International Tbk. - SDPC Hari Ini
Quarterly
Yearly
Income Statement
Revenue
Net Profit
Net Loss
Profit margin %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Revenue | Rp4,11 T | +4.93% |
| Cost of Revenue | Rp3,75 T | +4.6% |
| Gross Profit | Rp362,36 M | +8.37% |
| General Expenses, Depreciation, Interest | Rp234,9 M | +3.85% |
| Operating Profit | Rp127,46 M | +17.82% |
| Other Income | -Rp78,57 M | -2.38% |
| EBT | Rp48,9 M | +76.51% |
| Taxes | -Rp10,43 M | -3.3% |
| Net Income | Rp38,47 M | +127.24% |
Balance Sheet
Assets
Liabilities
Debt to Asset %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Total Assets | Rp1,96 T | +10.66% |
| Total Liabilities | Rp1,65 T | +10.47% |
| Total Equity | Rp315,42 M | +11.65% |
| Total Liabilities & Total Equity | Rp1,96 T | +10.66% |
Cash Flow
Operating
Investing
Finance
Net CF
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| CF from Operations | Rp88,1 M | -170.22% |
| CF from Investment | Rp38,64 M | +177.54% |
| CF from Financing | Rp40,09 M | -129.93% |
| Net Cash Flow | Rp9,37 M | -272.66% |